Asset Search
Displaying all 5 assets.
-
Description Overview of TEAEs Through Week 16 in All Treated Patients
Article Title: Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis
Publication Title: JAMA Dermatology -
Description Study Design and Patient DispositionAE indicates adverse event.aOne AE is not reported because it occurred before the first injection.
Article Title: Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis
Publication Title: JAMA Dermatology -
Description Other Secondary End Points in Intention-to-Treat Analysis Set at 16 Weeksa
Article Title: Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis
Publication Title: JAMA Dermatology -
Description Primary and Major Secondary Efficacy End Points at Week 16 in Intention-to-Treat Analysis Seta
Article Title: Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis
Publication Title: JAMA Dermatology -
Description Demographic and Baseline Characteristics
Article Title: Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis
Publication Title: JAMA Dermatology
Displaying all 5 assets.